The current understanding of LAM pathogenesis implicates somatic mutations in the TSC2 gene in sporadic LAM, and germline mutations in TSC1 or TSC2 in cases associated with tuberous sclerosis complex. Here, TSC2 is linked to lymphangioleiomyomatosis.